Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?

R Talotta, ES Robertson - Cytokine & growth factor reviews, 2021 - Elsevier
Antiphospholipid antibodies (aPLs), present in 1–5% of healthy individuals, are associated
with the risk of antiphospholipid syndrome (APS), which is the most common form of …

Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome

PG de Groot, B de Laat - Best Practice & Research Clinical Rheumatology, 2017 - Elsevier
The presence of antiphospholipid antibodies is one of the most common acquired risk
factors for thrombosis. Antiphospholipid antibodies is a collective term for a set of …

[HTML][HTML] Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome

N Melas - Thrombosis Update, 2021 - ncbi.nlm.nih.gov
With the implementation of a global vaccination plan, the year 2021 began with the hope of
definitively conquering the coronavirus disease 2019 (COVID-19) pandemic. The European …

Componente genético de las enfermedades reumatológicas autoinmunes

D Juárez-Melchor, P Munguía-Realpozo… - Reumatología clínica, 2022 - Elsevier
El propósito de esta revisión es presentar los principales aspectos del componente genético
de las enfermedades reumatológicas autoinmunes, incluyendo las características del …

A young woman with acute coronary syndrome and antiphospholipid syndrome. Is it the antiphospholipid syndrome or COVID-19 vaccination or classical risk as the …

SN Siagian, C Christianto - Journal of Medical Case Reports, 2024 - Springer
Background Acute coronary syndrome (ACS) in young women is poorly understood due to
underdiagnosis and undertreatment. One of the possible risk factors for ACS in young …

Genetic component of autoimmune rheumatological diseases

D Juárez-Melchor, P Munguía-Realpozo… - … Clínica (English Edition), 2022 - Elsevier
The purpose of this review is to present the main aspects of the genetic component of
autoimmune rheumatic diseases, including the characteristics of the multifactorial or …

[PDF][PDF] Патогенетически обоснованная профилактика неблагоприятных исходов экстракорпорального оплодотворения у женщин с наличием …

МИ Кривонос - 2020 - 1spbgmu.ru
Макацария Александр Давидович–академик РАН, доктор медицинских наук,
профессор, заведующий кафедрой акушерства и гинекологии Федерального …

Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects

MG Mosconi, F Caso, G Maraziti, C Kremer, L Costa… - 2021 - Springer
Dear Editor, Initially, the UK COVID-19 distribution strategy for the viral vector vaccine,
ChAdOx1 nCoV-19 (AZD1222), was to deliver a single dose to the entire population …

[PDF][PDF] Best Practice & Research Clinical Rheumatology

PG de Groot, B de Laat - Best Practice & Research Clinical …, 2017 - academia.edu
abstract The presence of antiphospholipid antibodies is one of the most common acquired
risk factors for thrombosis. Antiphospholipid antibodies is a collective term for a set of …

[PDF][PDF] The First Israel-Greece Meeting: Collaboration at its Best

E Toubi - ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016 - ima.org.il
High levels of circulating microvesicles (MVs), namely annexin V-bearing MVs, endothelial
and platelet MVs, have been associated with an increased risk of thrombosis. An increased …